Replies to post #31837 on $heff's $tation of $tocks & $olid DD

[$heff]

ronpopeil...AVNR ($2.84) has been trading volatile here as have most of the biotechs over the past few weeks. We are still two months out until the PDUFA date on Oct 30th. I think that the ANA meeting could provide some spark back into it. MM's are having a field day with it after taking it to $2.65 last week and back to $3.05 within 2 days to now $2.82. Hard to watch for sure but that is the reality of the market and sector now. I still believe that AVP-923 gets approved on Oct 30th but what the stock does between now and then will continue to be a bumpy ride. $heff

Message in reply to:

Hope to see a steady rise for AVNR as we head into september and october. AVNR is presenting at a prestigious conference in the next few weeks which should bring them attention. Institutional ownership has gone up a lot lately, analysts have buy rating and high price targets for the stock and FDA approval is quite strong. I'd like to see $6+ before FDA approval. Maybe $10 after approval and a possible partnership or buyout.